Pharmacodynamics of tepoxalin, sodium-salicylate and ketoprofen in an intravenous lipopolysaccharide inflammation model in broiler chickens

Journal of Veterinary Pharmacology and Therapeutics

Volumn 33, Issue 6, 2010, Pages 564-572

  De Boever, S ^a   Neirinckx, E A ^a   Meyer, E ^a   Beyaert, R ^a,b   De Backer, P ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HETEROPHILE ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; KETOPROFEN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; RWJ 20142; SALICYLATE SODIUM; TEPOXALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BODY TEMPERATURE; CHICKEN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; FEMALE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY TEMPERATURE; CHICKENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-1BETA; INTERLEUKIN-6; KETOPROFEN; LIPOPOLYSACCHARIDES; MALE; POULTRY DISEASES; PYRAZOLES; SODIUM SALICYLATE;

GALLUS GALLUS;

EID: 78349269553     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01184.x     Document Type: Article

References (54)

1. Anonymous (2001) Guideline for the conduct of efficacy studies for non-steroidal anti-inflammatory drugs. EMEA/CVMP/237/01-FINAL.
2. Anonymous (2002) Commission Decision 2002/657/EC implementing council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities, N° L221.
3. Anonymous (2003) Wijziging Vrijstellingsregeling artikel 2 Diergeneesmiddelenwet 1999.
4. Anonymous (2004) Draft Appendix A of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS No. 123).
5. Baert, K. (2003). Pharmacokinetics and pharmacodynamics of non-steroidal anti-inflammatory drugs in birds, PhD Thesis, Faculty of Veterinary Medicine of the University of Ghent.
6. Baert, K. & De Backer, P. (2003) Comparative pharmacokinetics of three non-steroidal anti-inflammatory drugs in five bird species. Comparative Biochemistry and Physiology Part C, 134, 25-33.
7. Baert, K., Duchateau, L., De Boever, S., Cherlet, M. & De Backer, P. (2005) Antipyretic effect of oral sodium salicylate after an intravenous E. coli LPS injection in broiler chickens. British Poultry Science, 46, 137-143.
8. Coceani, F. & Akarsu, E. (1998) Prostaglandin E2 in the pathogenesis of fever. An update. Annals of the New York Academy of Science, 856, 76-82.
9. D'Acquisto, F., May, M. & Ghosh, S. (2002) Inhibition of Nuclear Factor Kappa B (NF-κB): an emerging theme in anti-inflammatory therapies. Molecular Interventions, 2, 22-35.
10. Davidson, J., Abul, H., Milton, A. & Rotondo, D. (2001) Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain. Plugers Archive, 442, 526-533.
11. De Boever, S., Beyaert, R., Vandemaele, F., Baert, K., Duchateau, L., Goddeeris, B., De Backer, P. & Croubels, S. (2008) The influence of age and repeated lipopolysaccharide administration on body temperature and the concentration of interleukin-6 and IgM antibodies against lipopolysaccharide in broiler chickens. Avian Pathology, 31, 39-44.
12. De Boever, S., Croubels, S., Meyer, E., Sys, S., Beyaert, R., Ducatelle, R & De Backer, P. (2009a) Characterization of an intravenous lipopolysaccharide inflammation model in broiler chickens. Avian Pathology, 38, 403-411.
13. De Boever, S., Neirinckx, E., Baert, K., De Backer, P. & Croubels, S. (2009b) Pharmacokinetics of tepoxalin and its active metabolite in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics, 32, 97-100.
14. De Boever, S., Croubels, S., Demeyere, K., Lambrecht, B., De Backer, P. & Meyer, E. (2010) Flow cytometric differentiation of avian leukocytes and analysis of their intracellular cytokine production. Avian Pathology, 39, 41-46.
15. De Souza, G., Cardoso, R., Melo, M., Fabricio, A., Silva, V., Lora, M., De Brum-Fernandes, A., Rae, G., Ferreira, S. & Zampronio, A. (2002) A comparative study of the antipyretic effects of indomethacin and dipyrone in rats. Inflammation Research, 51, 024-032.
16. Doyle, S. & O'Neill, L. (2006) Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity. Biochemical Pharmacology, 72, 1102-1113.
17. 1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha. Neuropharmacology, 38, 1325-1333.
18. Fraifeld, V., Blaicher-Kulick, R., Degen, A. & Kaplanski, J. (1995) Is hypothalamic prostaglandin E2 involved in avian fever? Life Sciences, 56, 1343-1346.
19. Fraifeld, V. & Kaplanski, J. (1998) Brain eicosanoids and LPS fever: species and age differences. Progress in Brain Research, 115, 141-157.
20. Ghezzi, P., Melillo, G., Meazza, C., Sacco, S., Pellegrini, L., Asti, C., Porzio, S., Marullo, A., Sabbatini, V., Caselli, G. & Bertini, R. (1998) Differential contribution of R and S isomers in ketoprofen anti-inflammatory activity: role of cytokine modulation. The Journal of Pharmacology and Experimental Therapeutics, 287, 969-974.
21. Giuliano, F., Mitchell, J. & Warner, T. (2001) Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo. The Journal of Pharmacology and Experimental Therapeutics, 3, 894-900.
22. Hasegawa, T., Takagi, K. & Kitaichi, K. (1999) Effects of bacterial endotoxin on drug pharmacokinetics. Nagoya Journal of Medical Science, 62, 11-28.
23. Hayden, M. & Ghosh, S. (2008) Shared principles in NF-kappaB signaling. Cell, 132, 344-362.
24. Homer, L. M., Clarke, C. R. & Weingarten, A. J. (2005) Effect of dietary fat on oral bioavailability of tepoxalin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 287-291.
25. Huntjens, D., Danhof, M. & Della Pasqua, O. (2005) Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Reumatology, 44, 846-859.
26. 2-synthesizing enzymes in fever: differential transcriptional regulation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 283, R1104-R1117.
27. Kazmi, S., Plante, R., Visconti, V., Taylor, G., Zhou, L. & Lau, C. (1995) Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. Journal of Cellular Biochemistry, 57, 299-310.
28. Knecht, J. & Stork, G. (1974) Percentage and logarithmic procedures for calculation of calibration curves. Fresenius Zeitschrift fur Analytische Chemie, 270, 97-99.
29. Landegren, U. (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications of detection of lymphokines and cell surface antigens. Journal of Immunological Methods, 67, 379-388.
30. Lee, J. & Burckart, G. (1998) Nuclear Factor Kappa B: important transcription factor and therapeutic target. Journal of Clinical Pharmacology, 38, 981-993.
31. Lees, P. & Higgins, A. (1985) Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Veterinary Journal, 17, 83-96.
32. Lees, P., May, S. & McKellar, Q. (1991) Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: 1 General pharmacology. Journal of Small Animal Practice, 32, 183-193.
33. Macari, M., Furlan, R., Gregorut, F., Secato, E. & Guerreiro, J. (1993) Effects of endotoxin, interleukin-1 beta and prostaglandin injections on fever response in broilers. British Poultry Science, 34, 1035-1042.
34. Martin, L., Catania, A., Hiltz, M. & Lipton, J. (1991) Neuropeptide alpha-MSH antagonizes IL-6 and TNF-induced fever. Peptides, 12, 297-299.
35. Monshouwer, M. & Witkamp, R. (2000) Cytochromes and cytokines: changes in drug disposition in animals during an acute phase response: a mini-review. Veterinary Quarterly, 22, 17-20.
36. Neirinckx, E., Croubels, S., De Boever, S., Remon, J., Bosmans, T., Daminet, S., De Backer, P. & Vervaet, C. Species comparison of enantioselective oral bioavailability and pharmacokinetics of ketoprofen. Research in Veterinary Science, submitted.
37. Netea, M., Kullberg, B. & Van der Meer, J. (2000) Circulating cytokines as mediators of fever. Clinical Infectious Diseases, 31, S178-S184.
38. 2. Neuroendocrinology, 150, 1850-1860.
39. Pecchi, E., Dallaporta, M., Jean, A., Thirion, S. & Troadec, J-D. (2009) Prostaglandins and sickness behavior: old story, new insights. Physiology and Behavior, 97, 279-292.
40. Rainsford, K., Ying, C. & Smith, F. (1993) Selective effects of some 5-lipoxygenase inhibitors on synovial interleukin-1 (IL-1) production compared with IL-1 synthesis inhibitors. Agents and Actions, 39, C186-C188.
41. Rainsford, K., Ying, C. & Smith, F. (1996) Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin-1-synthesis. Journal of pharmacy and pharmacology, 48, 46-52.
42. Remick, D. & Ward, P. (2005) Evaluation of endotoxin models for the study of sepsis. Shock, 24, 7-11.
43. Ritchie, D., Argentieri, D., Aparicio, B., Plante, R., Lau, C. & Barbone, A. (1995) Cytokine-modulating activity of tepoxalin, a new potential antirheumatic. International Journal of Immunopharmacology, 17, 805-812.
44. Semrad, S. (1993) Comparative efficacy of flunixin, ketoprofen and ketorolac for treating endotoxemic neonatal calves. American Journal of Veterinary Research, 9, 1511-1516.
45. Takimoto, T., Sato, K., Akiba, Y. & Takahashi, K. (2008) Role of chicken TL1A on inflammatory responses and partial characterization of its receptor. The Journal of Immunolgy, 180, 8327-8332.
46. Tegeder, I., Pheilschifter, J. & Geisslinger, G. (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. The FASEB Journal, 15, 2057-2072.
47. Tsuboi, I., Tanaka, H., Nakao, M., Shigeki, S. & Itoh, K. (1995) Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: upregulation of TNF, IFN-γ and IL-2, in contrast to downregulation of IL-6 production. Cytokine, 4, 372-379.
48. Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P.G., Rubira, M.R. & Simpson, R.J. (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proceedings of the National Academy of Science of the United States of America, 83, 9679.
49. Waldman, S.A., Vitow, C., Osborne, B., Gillen, L., Argentieri, D.C., Wong, F.A., Smith, I.L., Chow, A.T., Misiti, J. & Bjornsson, T.D. (1996) Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers. Journal of Clinincal Pharmacology, 36, 462-468.
50. Willburger, R., Wittenberg, R., Schmidt, K., Kleemeyer, K. & Peskar, B. (1998) Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis. Acta Orthopedica Scandinavica, 69, 295-300.
51. Yang, K. & Lee, M. (2008) Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs. Archives of Pharmacal Research, 9, 1073-1086.
52. Yin, M., Yamamoto, Y. & Gaynor, R. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature, 396, 77-80.
53. Yoon, J., Kim, S., Hwang, S., Chang, S., Kang, S. & Chun, J. (2003) Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity. The Journal of Biological Chemistry, 278, 15319-15325.
54. Zhou, L., Ritchie, D., Wang, E., Barbone, A., Argentieri, D. & Lau, C. (1994) Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A. The Journal of Immunology, 153, 5026-5037.